**Core Concept**
Ovarian serous cystadenocarcinoma is a type of epithelial ovarian cancer, accounting for approximately 70% of all ovarian malignancies. The standard management of ovarian cancer involves surgical staging, followed by chemotherapy.

**Why the Correct Answer is Right**
For stage I ovarian cancer, as in this case, the next step after surgical staging would be adjuvant chemotherapy to reduce the risk of recurrence. This is because stage I ovarian cancer has a high risk of microscopic spread, and chemotherapy helps to eliminate any remaining malignant cells. The recommended chemotherapy regimen for ovarian cancer typically includes a combination of platinum-based agents, such as carboplatin, and a taxane, such as paclitaxel.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not provide any management plan for ovarian cancer.
**Option B:** This option is incorrect as it does not address the need for adjuvant chemotherapy in ovarian cancer.

**Clinical Pearl / High-Yield Fact**
It's essential to note that the management of ovarian cancer is highly individualized and depends on various factors, including the stage, grade, and histological type of the tumor, as well as the patient's overall health and preferences. A multidisciplinary team approach, including gynecologic oncologists, medical oncologists, and radiation oncologists, is crucial in developing an optimal treatment plan.

**Correct Answer: D. Adjuvant chemotherapy with a combination of carboplatin and paclitaxel.**